Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | ADH1B | P00325 | 1/20 | 0.34 |
| ▸ | ADH1C | P00326 | 1/20 | 0.34 |
| ▸ | ADH1A | P07327 | 1/20 | 0.34 |
| ▸ | ADH4 | P08319 | 1/20 | 0.34 |
| ▸ | ADH7 | P40394 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10997895 | 1.00 | DNM1 (0.39) | DNM1TSHRTHRBNAAAMEN1 | |
| SCHEMBL218088 | 1.00 | DNM1 (0.39) | DNM1TSHRTHRBNAAAMEN1 | |
| SCHEMBL253395 | 1.00 | DNM1 (0.39) | DNM1TSHRTHRBNAAAMEN1 | |
| SCHEMBL216576 | 1.00 | DNM1 (0.39) | DNM1TSHRTHRBNAAAMEN1 | |
| SCHEMBL253396 | 1.00 | DNM1 (0.39) | DNM1TSHRTHRBNAAAMEN1 | |
| SCHEMBL218089 | 1.00 | DNM1 (0.39) | DNM1TSHRTHRBNAAAMEN1 | |
| SCHEMBL10997899 | 1.00 | DNM1 (0.39) | DNM1TSHRTHRBNAAAMEN1 | |
| SCHEMBL9116589 | 0.90 | — | — | |
| SCHEMBL9313063 | 0.90 | — | — | |
| SCHEMBL23811417 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10570243-B2 | Non-tin catalyst for curing alkoxysilyl-containing polymer | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2020-02-25 | — | — | US | claimed |
| US-20180072837-A1 | NON-TIN CATALYST FOR CURING ALKOXYSILYL-CONTAINING POLYMER | MOMENTIVE PERFORMANCE MATERIALS INC. | 2018-03-15 | — | — | US | claimed |
| WO-2026105516-A1 | METHOD FOR FORMING MULTILAYER COATING FILM | 日本ペイント・オートモーティブコーティングス株式会社 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026105512-A1 | CLEAR COATING COMPOSITION | 日本ペイント・オートモーティブコーティングス株式会社 | 2026-05-21 | — | — | WO | disclosed |
| EP-4481009-A1 | COATING COMPOSITION AND METHOD FOR FORMING COATING FILM | Kansai Paint Co., Ltd. (JP) | 2024-12-25 | — | — | EP | disclosed |
| WO-2023157942-A1 | COATING COMPOSITION AND METHOD FOR FORMING COATING FILM | 関西ペイント株式会社 | 2023-08-24 | — | — | WO | disclosed |
| EP-2935490-B1 | ORGANOPOLYSILOXANE COMPOSITION SUITABLE FOR VULCANISATION INTO AN ELASTOMER AT ROOM TEMPERATURE AND NEW ORGANOPOLYSILOXANE POLYCONDENSATION CATALYSTS | ELKEM SILICONES FRANCE SAS (FR) | 2022-12-21 | — | — | EP | disclosed |
| EP-3362499-B1 | SYSTEMS AND METHODS FOR FORMING POLYURETHANES | EASTMAN CHEM CO (US) | 2021-09-22 | — | — | EP | disclosed |
| EP-2762240-B1 | METHOD FOR FORMING COATING FILM AND COATED ARTICLE | KANSAI PAINT CO LTD (JP) | 2020-11-04 | — | — | EP | disclosed |
| US-10640641-B2 | Curable coating compositions of silane functional polymers | KING INDUSTRIES (US) | 2020-05-05 | — | — | US | disclosed |
| US-20200062953-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES | 2020-02-27 | — | — | US | disclosed |
| US-20120225982-A1 | COMPOSITIONS OF A METAL AMIDINE COMPLEX AND SECOND COMPOUND, COATING COMPOSITIONS COMPRISING SAME | KING INDUSTRIES, INC. | 2012-09-06 | — | — | US | disclosed |
| US-20120070569-A1 | ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS | KING INDUSTRIES, INC. (US) | 2012-03-22 | — | — | US | disclosed |
| US-8088846-B2 | Organometallic compositions and coating compositions | KING INDUSTRIES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-7485729-B2 | Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(tetramethylguanidine)2(formate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes | KING INDUSTRIES, INC. (US) | 2009-02-03 | — | — | US | disclosed |
| US-20090011124-A1 | Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(1-methylimidazole)2(2-ethylhexanoate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes | HSIEH BING | 2009-01-08 | — | — | US | disclosed |
| EP-1778778-A2 | ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS | King Industries, Inc. (US) | 2007-05-02 | — | — | EP | disclosed |
| US-20060247341-A1 | Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(tetramethylguanidine)2(formate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes | KING INDUSTRIES, INC. | 2006-11-02 | — | — | US | disclosed |
| WO-2006022899-A2 | ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS | KING INDUSTRIES, INC. (US) | 2006-03-02 | — | — | WO | disclosed |
| US-20060036007-A1 | Organometallic compositions and coating compositions | KING INDUSTRIES, INC. (US) | 2006-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120070569-A1 | ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS | UROD, AOC1, AOC2 | DNM1 3318/4885TSHR 4810/4885THRB 4841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.